{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Inherited white matter disorders",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_clonazepam",
          "name": "Clonazepam"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_carbamazepine",
          "name": "Carbamazepine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_valproic_acid",
          "name": "Valproic Acid"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_phenytoin",
          "name": "Phenytoin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_primidone",
          "name": "Primidone"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_lithium",
          "name": "Lithium"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_antidepressants",
          "name": "Antidepressants"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_antipsychotics",
          "name": "Antipsychotics"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_chlordiazepoxide",
          "name": "Chlordiazepoxide"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_benzodiazepines",
          "name": "Benzodiazepines"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_thioridazine",
          "name": "Thioridazine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sodium_oxybate",
          "name": "Sodium Oxybate"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_cns_effect",
          "type": "Pathway",
          "label": "CNS Depression Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adverse_effect",
          "type": "Phenotype",
          "label": "Exacerbated White Matter Disorders",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_clonazepam",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知催眠作用导致中枢神经抑制"
        },
        {
          "source": "drug_clonazepam",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "抑制作用可能加重白质病变"
        },
        {
          "source": "drug_carbamazepine",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "同类药物，引发中枢神经抑制"
        },
        {
          "source": "drug_carbamazepine",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "加重已有病症的风险"
        },
        {
          "source": "drug_valproic_acid",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "同样引起中枢抑制"
        },
        {
          "source": "drug_valproic_acid",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能导致预期外的病理变化"
        },
        {
          "source": "drug_phenytoin",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "已知中枢抑制作用"
        },
        {
          "source": "drug_phenytoin",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能对现有白质问题产生负面影响"
        },
        {
          "source": "drug_primidone",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "引发中枢神经抑制的潜在机制"
        },
        {
          "source": "drug_primidone",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在对白质损害的加重"
        },
        {
          "source": "drug_lithium",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "影响神经传导，可能加重症状"
        },
        {
          "source": "drug_lithium",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与当前病症的不良交互"
        },
        {
          "source": "drug_antidepressants",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致情绪促进对症状的反弹"
        },
        {
          "source": "drug_antidepressants",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.75,
          "agent": "提及已有白质病的伴随症状加重"
        },
        {
          "source": "drug_antipsychotics",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "对中枢神经的影响"
        },
        {
          "source": "drug_antipsychotics",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.75,
          "agent": "加重已有白质病症"
        },
        {
          "source": "drug_chlordiazepoxide",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "抑制中枢神经活动"
        },
        {
          "source": "drug_chlordiazepoxide",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.7,
          "agent": "可能加重相关症状"
        },
        {
          "source": "drug_benzodiazepines",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "已知风险，抑制中枢神经"
        },
        {
          "source": "drug_benzodiazepines",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.7,
          "agent": "加重白质相关症状"
        },
        {
          "source": "drug_thioridazine",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "对中枢神经有抑制作用"
        },
        {
          "source": "drug_thioridazine",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.65,
          "agent": "导致已有病症的加重"
        },
        {
          "source": "drug_sodium_oxybate",
          "target": "n_cns_effect",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "抑制神经活动"
        },
        {
          "source": "drug_sodium_oxybate",
          "target": "n_adverse_effect",
          "relation": "causes",
          "weight": 0.65,
          "agent": "风险考量可能性加重"
        }
      ],
      "conflict_hotspots": [
        {
          "topic": "Drug Safety in Inherited White Matter Disorders",
          "pro_nodes": [
            "n_cns_effect"
          ],
          "con_nodes": [
            "n_adverse_effect"
          ],
          "note": "中枢神经抑制与白质病症加重之间的直接冲突"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "现有证据支持部分药物仍在特定期间内使用，使用时需谨慎监督",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "某些患者可能在短期内有可接受的治疗响应，但长期使用风险未明",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "中心性药物的安全性对于白质疾病患者的充分数据是否足够",
      "每种药物对白质结构的具体影响是否得到了充分理解"
    ],
    "falsification_tests": [
      "临床研究是否显示特定药物的长期使用与白质病患者的进展相关",
      "是否有证据表明短期使用不会导致不良长期效果"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供损害与效益的详细对比资料",
      "审查已知冲突及边际效益的文献"
    ]
  }
}